Figure 4.Laboratory values of blood cell counts for case 3. (A)
Neutrophils; (B) Lymphocytes; (C) White blood cells, WBC; (D)
Platelets; (E) Red blood cells, RBC (F) Hemoglobin, Hgb; (G) Hematocrit, Hct; (H) Prostate specific
antigen (PSA) level. The patient was enrolled in abiraterone acetate (CYP17 inhibitor) trial for 90
days indicated by vertical dash lines. The patient also received G-CSF
(Neulasta) on the day of chemotherapy except during the treatment with
abiraterone acetate. Filled triangle indicates day of chemotherapy; open
square indicates fasting, arrow indicates testosterone application (cream 1%).
Normal ranges of laboratory values are indicated by horizontal dash lines; (I)
Self-reported side-effects after chemotherapy for case 3. Data represent
the average of 5 cycles of chemo-alone vs the average of 7 cycles of
chemo-fasting treatments.
